Last $1.80 USD
Change Today +0.20 / 12.50%
Volume 2.7K
VNRX On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

volitionrx ltd (VNRX) Snapshot

Open
$1.74
Previous Close
$1.60
Day High
$1.80
Day Low
$1.74
52 Week High
03/6/14 - $3.25
52 Week Low
11/12/13 - $1.25
Market Cap
24.2M
Average Volume 10 Days
12.8K
EPS TTM
--
Shares Outstanding
13.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VOLITIONRX LTD (VNRX)

Related News

No related news articles were found.

volitionrx ltd (VNRX) Related Businessweek News

No Related Businessweek News Found

volitionrx ltd (VNRX) Details

VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.

7 Employees
Last Reported Date: 04/28/14

volitionrx ltd (VNRX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Chief Medical Officer and Head of US Operatio...
Total Annual Compensation: --
Secretary
Total Annual Compensation: --
Chief Scientific Officer of Hypergenomics Pte...
Total Annual Compensation: --
Chief Scientific Officer of Belgian Volition ...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

volitionrx ltd (VNRX) Key Developments

VolitionRX Limited Announces Executive Changes

On July 1, 2014, Malcolm Lewin resigned from his positions as Chief Financial Officer and Treasurer of VolitionRX Limited. On July 1, 2014, Mike O'Connell was appointed as Chief Financial Officer and Treasurer of the company to serve until his successor is duly appointed. On July 1, 2014, Mr. O'Connell accepted such appointment. Mike O'Connell is presently the CEO of Isosceles. Mr. O'Connell was appointed to serve a Chief Financial Officer and Treasurer because of his extensive financial and accounting knowledge.

VolitionRx Limited Appoints Dr. Habib Skaff to its Board of Directors

VolitionRx Limited announced appointment of Dr. Habib Skaff to its Board of Directors, effective June 1, 2014. Dr. Skaff assumes the role of a non-executive director, providing independent expertise to the Board. Dr. Skaff will represent the interests of VolitionRx's shareholders alongside Dr. Martin (Dill) Faulkes (Executive Chairman), Cameron Reynolds (President and Chief Executive Officer) and non-executive directors Guy Innes and Dr. Alan Colman. Dr. Skaff has served on VolitionRx's Scientific Advisory Board since 2011, and has a background in synthetic chemistry.

VolitionRX Ltd Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 02:30 PM

VolitionRX Ltd Presents at LD MICRO 4th Annual Micro-Cap Invitational, Jun-04-2014 02:30 PM. Venue: Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, CA 90049, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNRX:US $1.80 USD +0.20

VNRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VNRX.
View Industry Companies
 

Industry Analysis

VNRX

Industry Average

Valuation VNRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VOLITIONRX LTD, please visit www.volitionrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.